COVID-19 Clinical Trials
Clinical trials help researchers develop new and better treatments. The information they provide is the only way for medical breakthroughs to reach the public. During the current COVID-19 pandemic, it’s vital that patients and healthy volunteers participate in research related to the virus and its effects on our physical and mental health.
At this time, we invite to you open a profile through MyChart so that we are able to know your preferred areas of interest so our recruitment team may contact you with trials as they become available.
We anticipate COVID vaccine trials at Yale will be opening soon. If you are interested in being notified and/or participating, please complete the form on the COVID Vaccine Studies button on the left.
If you have questions or concerns, please contact us at helpusdiscover@yale.edu or call 1-877-978-8343.
COVID-19 Clinical Trials
- COVID-19 Inpatient, COVID-19 OutpatientCONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized PatientsPrincipal Investigator: Mahalia S. Desruisseaux
- Diseases of the Respiratory Systems, COVID-19 InpatientTofacitinib for Treatment of Moderate COVID-19 (I-TOMIC)Principal Investigator: Hyung Chun
- COVID-19 VaccineStudy to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy AdultsPrincipal Investigator: Onyema Ogbuagu
- COVID-19 Inpatient, COVID-19 OutpatientA Study of LAM-002A for the Prevention of Progression of COVID-19Principal Investigator: Charles Dela Cruz
- Diseases of the Respiratory Systems, COVID-19 InpatientStudy to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care TreatmentPrincipal Investigator: Onyema Ogbuagu